COMPANY EXECUTIVES IN TORONTO TO RING OPENING BELL ON DECEMBER 14TH

Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it has complied with all the conditions listed in the conditional listing approval delivered by the Toronto Stock Exchange (the “TSX”) in connection with the listing of its subordinate voting shares (the “Shares”) on the TSX.

“Curaleaf’s official listing on the Toronto Stock Exchange marks an incredible day not just for our company, but the entire global cannabis industry,” said Executive Chairman Boris Jordan. “As Curaleaf is now eligible for inclusion into indexes such as TSX and MSCI, this uplisting will ultimately provide significantly higher access to an even broader set of institutional investors from around the world and increase our stock’s liquidity long term. I am as confident as ever in the direction we are headed and I am grateful to the TSX, our shareholders, partners, and everyone in the company for helping get us here today. We look forward to being in Toronto for today’s opening bell.”

“This is a monumental week for our team, and for the entire Curaleaf community,” said Curaleaf CEO Matt Darin. “With greater access to global financial institutions and resources for our business, our team is eager to reach new heights as we continue cultivating, distributing, and retailing the best possible cannabis products to consumers the world over. I want to thank everyone – especially our 5200 team members - who have contributed to this achievement. I am thrilled to begin the new year as we continue to work in the best interest of the Company and our stakeholders and explore new ways to enhance lives by cultivating, sharing and celebrating the power of the plant."

The Company further announced that the Shares will commence trading on the TSX on December 14, 2023 under the ticker symbol “CURA” (the “TSX Listing”). No action is required in order to continue trading the Subordinate Voting Shares as a result of the TSX Listing. There will be no change in the Company’s CUSIP.

In connection with the TSX Listing, the Shares will be delisted from the Canadian Securities Exchange (the “CSE”) at the close of markets on December 13, 2023.

Curaleaf will celebrate this milestone by ringing the opening bell of the TSX in Toronto on Thursday, December 14, 2023. The Company’s Chief Executive Officer, Matt Darin, and the Company’s Executive Chairman, Boris Jordan, will be joined by members of Curaleaf’s senior management team at the event.

This news release does not constitute an offer to sell or a solicitation to buy such securities of the Company, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which an offer, solicitation or sale would be unlawful.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231214242885/en/

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
media@curaleaf.com

Tags

More Like This

Curaleaf Completes Acquisition of Northern Green Canada

Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply

Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

Tilray Expands Medical Cannabis Portfolio in Germany

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License

Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization